Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.

Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.

Item
http://www.wikidata.org/entity/Q34650359
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.A critical appraisal of atomoxetine in the management of ADHDA review of atomoxetine effects in young people with developmental disabilitiesEfficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a reviewA review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.An update on medication management of behavioral disorders in autism.What's in the pipeline? Drugs in development for autism spectrum disorder.Safety of medicines used for ADHD in children: a review of published prospective clinical trials.The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.Treatment options for the management of pervasive developmental disorders.An update on the comorbidity of ADHD and ASD: a focus on clinical management.Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
P2860

Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.

Item
http://www.wikidata.org/entity/Q34650359
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Long-term treatment with atomo ...... an open-label extension study.
@ast
Long-term treatment with atomo ...... an open-label extension study.
@en
Long-term treatment with atomo ...... an open-label extension study.
@nl
type
label
Long-term treatment with atomo ...... an open-label extension study.
@ast
Long-term treatment with atomo ...... an open-label extension study.
@en
Long-term treatment with atomo ...... an open-label extension study.
@nl
prefLabel
Long-term treatment with atomo ...... an open-label extension study.
@ast
Long-term treatment with atomo ...... an open-label extension study.
@en
Long-term treatment with atomo ...... an open-label extension study.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Long-term treatment with atomo ...... an open-label extension study.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921